| The immune landscape of cancer V Thorsson, DL Gibbs, SD Brown, D Wolf, DS Bortone, THO Yang, ... Immunity 48 (4), 812-830. e14, 2018 | 4345 | 2018 |
| Comprehensive molecular profiling of lung adenocarcinoma Cancer Genome Atlas Research Network Nature 511 (7511), 543, 2014 | 3801 | 2014 |
| Genomic classification of cutaneous melanoma R Akbani, KC Akdemir, BA Aksoy, M Albert, A Ally, SB Amin, H Arachchi, ... Cell 161 (7), 1681-1696, 2015 | 2652 | 2015 |
| Integrated genomic characterization of papillary thyroid carcinoma N Agrawal, R Akbani, BA Aksoy, A Ally, H Arachchi, SL Asa, JT Auman, ... Cell 159 (3), 676-690, 2014 | 2482 | 2014 |
| Integrated genomic characterization of oesophageal carcinoma Cancer Genome Atlas Research Network Nature 541 (7636), 169, 2017 | 1266 | 2017 |
| B7-H3: a costimulatory molecule for T cell activation and IFN-γ production AI Chapoval, J Ni, JS Lau, RA Wilcox, DB Flies, D Liu, H Dong, GL Sica, ... Nature immunology 2 (3), 269-274, 2001 | 1238 | 2001 |
| B7-H4, a molecule of the B7 family, negatively regulates T cell immunity GL Sica, IH Choi, G Zhu, K Tamada, SD Wang, H Tamura, AI Chapoval, ... Immunity 18 (6), 849-861, 2003 | 1021 | 2003 |
| Rescue of exhausted CD8 T cells by PD-1–targeted therapies is CD28-dependent AO Kamphorst, A Wieland, T Nasti, S Yang, R Zhang, DL Barber, ... Science 355 (6332), 1423-1427, 2017 | 898 | 2017 |
| Proliferation of PD-1+ CD8 T cells in peripheral blood after PD-1–targeted therapy in lung cancer patients AO Kamphorst, RN Pillai, S Yang, TH Nasti, RS Akondy, A Wieland, ... Proceedings of the National Academy of Sciences 114 (19), 4993-4998, 2017 | 725 | 2017 |
| Tumor microenvironment of metastasis in human breast carcinoma: a potential prognostic marker linked to hematogenous dissemination BD Robinson, GL Sica, YF Liu, TE Rohan, FB Gertler, JS Condeelis, ... Clinical cancer research 15 (7), 2433-2441, 2009 | 400 | 2009 |
| Modulation of T-cell-mediated immunity in tumor and graft-versus-host disease models through the LIGHT co-stimulatory pathway K Tamada, K Shimozaki, AI Chapoval, G Zhu, G Sica, D Flies, T Boone, ... Nature medicine 6 (3), 283-289, 2000 | 383 | 2000 |
| A grading system of lung adenocarcinomas based on histologic pattern is predictive of disease recurrence in stage I tumors G Sica, A Yoshizawa, CS Sima, CG Azzoli, RJ Downey, VW Rusch, ... The American journal of surgical pathology 34 (8), 1155-1162, 2010 | 370 | 2010 |
| Genomic organization and expression analysis of B7-H4, an immune inhibitory molecule of the B7 family IH Choi, G Zhu, GL Sica, SE Strome, JC Cheville, JS Lau, Y Zhu, DB Flies, ... The Journal of Immunology 171 (9), 4650-4654, 2003 | 365 | 2003 |
| B7-H1 costimulation preferentially enhances CD28-independent T-helper cell function H Tamura, H Dong, G Zhu, GL Sica, DB Flies, K Tamada, L Chen Blood, The Journal of the American Society of Hematology 97 (6), 1809-1816, 2001 | 361 | 2001 |
| The integrated genomic landscape of thymic epithelial tumors M Radovich, CR Pickering, I Felau, G Ha, H Zhang, H Jo, KA Hoadley, ... Cancer cell 33 (2), 244-258. e10, 2018 | 306 | 2018 |
| Vimentin is required for lung adenocarcinoma metastasis via heterotypic tumor cell–cancer-associated fibroblast interactions during collective invasion AM Richardson, LS Havel, AE Koyen, JM Konen, J Shupe, WG Wiles IV, ... Clinical cancer research 24 (2), 420-432, 2018 | 213 | 2018 |
| Characteristics and outcomes of patients with metastatic KRAS-mutant lung adenocarcinomas: the lung cancer mutation consortium experience B El Osta, M Behera, S Kim, LD Berry, G Sica, RN Pillai, TK Owonikoko, ... Journal of thoracic oncology 14 (5), 876-889, 2019 | 194 | 2019 |
| Metabolomic profiling reveals potential markers and bioprocesses altered in bladder cancer progression N Putluri, A Shojaie, VT Vasu, SK Vareed, S Nalluri, V Putluri, ... Cancer research 71 (24), 7376-7386, 2011 | 194 | 2011 |
| Disruption of STAT3 by niclosamide reverses radioresistance of human lung cancer S You, R Li, D Park, M Xie, GL Sica, Y Cao, ZQ Xiao, X Deng Molecular cancer therapeutics 13 (3), 606-616, 2014 | 184 | 2014 |
| Niclosamide overcomes acquired resistance to erlotinib through suppression of STAT3 in non–small cell lung cancer R Li, Z Hu, SY Sun, ZG Chen, TK Owonikoko, GL Sica, SS Ramalingam, ... Molecular cancer therapeutics 12 (10), 2200-2212, 2013 | 176 | 2013 |
Taofeek K. Owonikoko, MD/PhDUniversity of PittsburghVerified email at upmc.edu
